Results 121 to 130 of about 113,982,624 (231)
Sjögren’s syndrome is a heterogeneous autoimmune disorder that may be associated with systemic manifestations involving multiple organs. We herein reported a rare combination of immunoglobulin A nephropathy; non-cirrhotic portal fibrosis; and ...
Xiuhong Wang +6 more
doaj +1 more source
ABSTRACT Aim Patients with chronic kidney disease (CKD) have an increased cardiovascular risk. Since neutrophils and neutrophil‐borne proteins contribute to cardiovascular disease, we analyzed the neutrophil phenotype in patients with CKD who presented with a spectrum of cardiovascular comorbidities.
Sonja Vondenhoff +22 more
wiley +1 more source
Involvement of Bacterial Antigens in Immunoglobulin A Nephropathy [PDF]
To investigate the involvement of bacterial antigens in Immunoglobulin A (IgA) nephropathy, we measured IgA, IgG and IgM antibodies to gram-negative Escherichia coli (E.coli) and Haemophilus influenzae (H.influenzae) by ELISA in 24 patients (11 males and
Sekiguchi, Yoshitaka +6 more
core
Cancer in IgA nephropathy; a letter to the editor on current findings [PDF]
Maryam ALem +5 more
doaj +1 more source
IgA nephropathy in a child with X-linked agammaglobulinemia: a case report
Background X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations in the Bruton tyrosine kinase (BTK) gene. Individuals diagnosed with XLA are at an increased risk of developing autoimmune diseases.
Yuanjin Song +4 more
doaj +1 more source
This real‐world observational study enrolled 256 patients with type 2 diabetes and chronic kidney disease (T2D‐CKD). After 12 months of finerenone treatment, 45 patients completed follow‐up. Finerenone was associated with significant improvements in insulin resistance markers (HOMA‐IR, TyG index), lipid profile (LDL‐C), glycemic control (HbA1c), and ...
Xin Zhao +4 more
wiley +1 more source
The course of IgA nephropathy (IgAN) is highly variable and ranges from a totally benign condition to end-stage renal disease in approximately one third of cases.
Małgorzata Wągrowska-Danilewicz +1 more
core +1 more source
BackgroundThe mechanisms of action of mycophenolate mofetil (MMF) and hydroxychloroquine (HCQ) differ in the treatment of IgA nephropathy (IgAN), and the two may have a synergistic effect in delaying disease progression.MethodsThis multicenter ...
Yang Yang +10 more
doaj +1 more source
Immunological and genetic factors associated with type 1 diabetic nephropathy [PDF]
Väitöskirjaei tietoa saavutettavuudesta unknown ...
Korpinen, Eija
core
Disease modification in immunoglobulin A nephropathy
ABSTRACT With the rapidly expanding therapeutic landscape in IgA nephropathy, that incorporates new drugs with varied mechanisms of action, many of which may lead to modification of the fundamental pathophysiology of the world's commonest glomerular disease, thoughts are now turning to how we should define disease modification in IgA ...
openaire +2 more sources

